Document is current

Article History

Received: 20 May 2022

Accepted: 3 November 2022

First Online: 7 December 2022

Declarations

:

: Fabian Sehn, Hartwig Büttner: Part-time employee of Takeda; the present publication has been prepared independently and outside of the employment; the employer is not involved in any of subjects dealt with in this publication and did not provide any form of support. Sven Perner: Consultant: Ventana Medical Systems, Roche, Novartis, Astellas, Bristol-Myers Squibb, MetaSystems, Merck Serono, MSD. Research: Ventana Medical Systems, Roche, Bristol-Myers Squibb, MSD, Boehringer-Ingelheim. Lectures/Speaker/Honoraria: Ventana Medical Systems, Roche, Novartis, Astellas, Bristol-Myers Squibb, MetaSystems, Merck Serono, MSD. Mario W. Kramer: Honoraria/Consultation: Bayer, BMS, Eusai, Novartis, Merck, MSD, Pfizer, Roche. Travel Grants: Ipsen, Janssen, Merck, Novartis. Axel S. Merseburger: Lectures/Speaker/Honoraria: AstraZeneca, Bristol-Myers Squibb, Eisai, Ipsen, MSD, Merck Serono, Janssen, Takeda, TEVA, Astellas, Novartis, Pfizer und Roche. Consultant: AstraZeneca, Astellas, Bristol-Myers Squibb, Ipsen, Janssen, EUSAPharm, MSD, Merck Serono, Novartis, Takeda, Teva, Pfizer und Roche. Research and clinical trials: AstraZeneca, Astellas, Bristol-Myers Squibb, Ipsen, Janssen, EUSAPharm, MSD, Merck Serono, Novartis, Takeda, Teva, Pfizer und Roche. Marie C. Roesch: Lectures/Honoraria/Travel Grants: Ipsen, Novartis, Sanofi, Solution Akademie. Beate Godau, Marten Müller, Semih Sarcan , Anne Offermann declare that they have no conflict of interest.

: No human nor animal subjects have been involved in the presented publication.

Free to read: This content has been made available to all.